These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure. Ramchandren S; Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Estilow T; Shy ME; Ann Neurol; 2021 Feb; 89(2):369-379. PubMed ID: 33222249 [TBL] [Abstract][Full Text] [Related]
30. Intraepidermal nerve fibre density as biomarker in Charcot-Marie-Tooth disease type 1A. Hartmannsberger B; Doppler K; Stauber J; Schlotter-Weigel B; Young P; Sereda MW; Sommer C Brain Commun; 2020; 2(1):fcaa012. PubMed ID: 32954280 [TBL] [Abstract][Full Text] [Related]
31. The Foot Posture Index: Rasch analysis of a novel, foot-specific outcome measure. Keenan AM; Redmond AC; Horton M; Conaghan PG; Tennant A Arch Phys Med Rehabil; 2007 Jan; 88(1):88-93. PubMed ID: 17207681 [TBL] [Abstract][Full Text] [Related]
32. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease. Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905 [TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene. Sanmaneechai O; Feely S; Scherer SS; Herrmann DN; Burns J; Muntoni F; Li J; Siskind CE; Day JW; Laura M; Sumner CJ; Lloyd TE; Ramchandren S; Shy RR; Grider T; Bacon C; Finkel RS; Yum SW; Moroni I; Piscosquito G; Pareyson D; Reilly MM; Shy ME; Brain; 2015 Nov; 138(Pt 11):3180-92. PubMed ID: 26310628 [TBL] [Abstract][Full Text] [Related]
34. [Validation of the Spanish version of the Charcot-Marie-Tooth disease Pediatric Scale (CMTPedS)]. Pitarch-Castellano I; Argente-Escrig H; Frasquet M; Damià-Vidal M; Canet-Barrera A; Sevilla T; Burns J Rev Neurol; 2022 Feb; 74(3):78-82. PubMed ID: 35084732 [TBL] [Abstract][Full Text] [Related]
35. Charcot-Marie-Tooth disease complicating type 2 diabetes. Win HH; Davenport C; Delaney S; Kelly M; Smith D J Am Podiatr Med Assoc; 2011; 101(4):349-52. PubMed ID: 21817005 [TBL] [Abstract][Full Text] [Related]
36. Laryngeal electromyographic findings in Charcot-Marie-Tooth disease type II. Dray TG; Robinson LR; Hillel AD Arch Neurol; 1999 Jul; 56(7):863-5. PubMed ID: 10404989 [TBL] [Abstract][Full Text] [Related]
37. p62/sequestosome-1 as a severity-reflecting plasma biomarker in Charcot-Marie-Tooth disease type 1A. Yoon BA; Kim YH; Nam SH; Lee HJ; Oh SI; Kim N; Kim KH; Jo YR; Kim JK; Choi BO; Park HT Sci Rep; 2024 May; 14(1):10972. PubMed ID: 38745059 [TBL] [Abstract][Full Text] [Related]
39. The use of Charcot-Marie-Tooth Neuropathy Score. Padua L; Schenone A; Pazzaglia C; Pareyson D Eur J Phys Rehabil Med; 2009 Jun; 45(2):291-2. PubMed ID: 19532113 [No Abstract] [Full Text] [Related]
40. Diabetes coexistent with Charcot-Marie-Tooth disease presenting as a recurrent foot ulcer misdiagnosed as diabetic foot: A case report. Yan Z; Chen D; Yao L; Wang C; Ran XW J Diabetes Investig; 2021 Nov; 12(11):2099-2101. PubMed ID: 33991180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]